Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on December 15th, 2022%
A clinical trial is underway testing the safety and feasibility of focused ultrasound to enable use of blood tests to monitor a patient’s glioblastoma, a form of brain cancer. . . . → Read More: Trial Testing Ultrasound for Brain Cancer Liquid Biopsies
By Alan, on December 12th, 2022%
An experiment is underway testing a bone repair biomaterial in lab mice under weightless conditions on the International Space Station. . . . → Read More: Bone Regeneration Experiment Begun on Space Station
By Alan, on December 7th, 2022%
A technology investment company is partnering with a Silicon Valley incubator program to support start-up businesses developing new types of semiconductors. . . . → Read More: Venture Investor to Back Semiconductor Start-Ups
By Alan, on December 6th, 2022%
The Food and Drug Administration authorized for marketing an algorithm-driven medical device for diagnosing a common, but difficult to detect, type of heart failure. . . . → Read More: FDA Clears AI Heart Failure Detection System
By Alan, on December 2nd, 2022%
Results of a clinical trial show a nasal swab dispensing an opioid antidote transfers more of the antidote into the blood stream than syringe injections or nasal sprays. . . . → Read More: Trial Shows Fast-Absorbing Opioid Overdose Nasal Swab
By Alan, on December 1st, 2022%
A developer of virtual tissue staining systems aided by algorithms for medical images began public operations today, raising $15.2 million in venture funds. . . . → Read More: Virtual Pathology Image Company Opens, Raises $15.2M
By Alan, on November 30th, 2022%
A company creating extended-release delivery techniques for eye therapies is raising $11.9 million in its first venture funding round. . . . → Read More: Sustained-Released Eye Treatment Company Raises $11.9M
By Alan, on November 29th, 2022%
Results of a clinical trial reveal an optimal dose for an insulin capsule that in 12 weeks reduces blood glucose levels in patients with type 2 diabetes. . . . → Read More: Trial Shows Insulin Capsules Reduce Blood Glucose Levels
By Alan, on November 28th, 2022%
A new company developing DNA as a data storage medium with sustainable processes is raising €5 million ($US 5.22 million) in seed funding. . . . → Read More: DNA Storage Start-Up Gains €5M in Seed Funds
By Alan, on November 23rd, 2022%
A developer of remote health tracking technology says the Food and Drug Administration cleared its continuous patient monitoring system for clinical use. . . . → Read More: FDA Clears Digital Health Monitoring System
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|